MASSACHUSETTS FINANCIAL SERVICES CO /MA/ - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 195 filers reported holding SANGAMO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.0%.

Quarter-by-quarter ownership
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$118,933
-55.6%
198,288
-3.7%
0.00%
Q2 2023$267,651
-27.8%
205,885
-2.3%
0.00%
Q1 2023$370,894
-45.5%
210,735
-2.7%
0.00%
Q4 2022$680,416
-66.8%
216,693
-48.2%
0.00%
-100.0%
Q3 2022$2,051,000
+188.5%
418,562
+242.0%
0.00%
Q1 2022$711,000
-21.7%
122,387
+1.0%
0.00%
Q4 2021$908,000
+82.7%
121,133
+119.7%
0.00%
Q3 2021$497,00055,1350.00%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Lombard Odier Asset Management (Switzerland) SA 1,539,994$11,550,0000.74%
Golden State Equity Partners 143,768$1,078,0000.54%
Rhenman & Partners Asset Management AB 765,000$5,975,0000.40%
WASATCH ADVISORS LP 10,960,982$82,207,0000.34%
KLK CAPITAL MANAGEMENT LLC 44,323$332,0000.32%
EMC Capital Management 61,394$460,0000.25%
Rokos Capital Management LLP 539,860$4,108,0000.25%
Long Focus Capital Management, LLC 245,000$1,838,0000.24%
Vanguard Capital Wealth Advisors 33,380$250,0000.18%
Fort Sheridan Advisors LLC 74,898$562,0000.16%
View complete list of SANGAMO THERAPEUTICS INC shareholders